Analyst Ratings For Hikma Pharmaceuticals (LON:HIK)
Today, Jefferies Group reiterated its Underperform rating on Hikma Pharmaceuticals (LON:HIK) with a price target of GBX 895.
Some recent analyst ratings include
- 1/17/2018-Jefferies Group Reiterated Rating of Underperform.
- 1/15/2018-JPMorgan Chase & Co. Reiterated Rating of Neutral.
- 12/20/2017-Numis Securities Reiterated Rating of Buy.
- 12/1/2017-Morgan Stanley Reiterated Rating of Equal weight.
- 11/15/2017-Peel Hunt Reiterated Rating of Hold.
Recent Trading Activity for Hikma Pharmaceuticals (LON:HIK)
Shares of Hikma Pharmaceuticals closed the previous trading session at 1,015.50 up +8.00 0.79% with 10.229999542236328 shares trading hands.